Inflammatory cytokine production in whole blood modified by liposome-encapsulated hemoglobin

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 26, Issue 5-6, 1998, Pages 559-570

  Niwa, Koichi ^a   Ikebuchi, Kenji ^a   Fujihara, Mitsuhiro ^a   Abe, Hideki ^a   Wakamoto, Shinobu ^a   Ito, Takatoshi ^a   Yamaguchi, Miki ^a   Sekiguchi, Sadayoshi ^a  

^a JAPANESE RED CROSS SOCIETY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CYTOLOGY; HEMOGLOBIN; IMMUNOLOGY; POLYSACCHARIDES; RNA;

INTERLEUKIN 6; MRNA EXPRESSION; NEO RED CELLS; TUMOR NECROSIS FACTOR;

BLOOD SUBSTITUTES;

BLOOD SUBSTITUTE; CARBON DIOXIDE; CYTOKINE; HEMOGLOBIN; HEPARIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOSOME; MESSENGER RNA; RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; CYTOKINE PRODUCTION; DOSE RESPONSE; ERYTHROCYTE; HUMAN; HUMAN CELL; INCUBATOR; INFLAMMATION; NORMAL HUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; VENOUS BLOOD;

EID: 0032212673     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199809117475     Document Type: Article

References (15)

1. R.M. Winslow. Hemoglobin-based red cell substitutes: unsolved issues and future directions. In Artificial Red Cells, edited by E. Tsuchida, p117-130 (1995).
2. A.S. Rudolph. Encapsulated hemoglobin: current issues and future goals. Art. Cells. Blood Subs. and Immob. Biotech. 22:347-760 (1994).
3. A.S. Rudolph, R.W. Klipper, B. Goins and W.T. Phillips. In vivo biodistribution of a radiolabeled blood substitutes: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit. Proc. Natl. Acad. Sci. USA 88:10976-10980 (1991).
4. L.A. Langdale, R.V. Maier, L Wilson, T.H. Pohlman, L.G. Williams and C.L. Rice. Liposome-encapsulated hemoglobin inhibits tumor necrosis factor release from rabbit alveolar macrophages by a posttranscriptional mechanism. J. Leukoc. Biol. 52:679-686 (1992).
5. A.S. Rudolph, R.O. Cliff, B.J. Spargo and H. Spielberg. Transient changes in the mononuclear phagocyte system following administration of the blood substitute liposome-encapsulated haemoglobin. Biomaterials 15:796-804 (1994).
6. P. Bankey, E. Beecherl, D Bibus. D. See and K McIntyre. Liposomes modulate Kupffer cell endotoxin response. Arch Surg. 130:1266-1272 (1995).
7. F.M. Rollwagen, W.C.M. Gafney, N.D. Pacheco, T.A. Davis, T.M. Hickey, T.B. Nielsen and A.S. Rudolph. Multiple responses to administration of liposome-encapsulated hemoglobin (LEH): Effects on hematopoiesis and IL-6 levels. Exp. Hematol. 24:429-436 (1996).
8. A.S. Rudolph, R. Cliff, V Kwasiborski, L. Neville, F. Abdullah and R. Rabinovici. Liposome-encapsulated hemoglobin modulates lipopolysaccharide-induced tumor necrosis factor-alpha production in mice. Crit. Care Med. 25:460-468 (1997).
9. X.-L. Zhu, WC.M. Gafney, ND. Pacheco and F.M. Rollwagen. Kinetics of cytokine gene expression in macrophage and endothelial cell lines following liposome encapsulated haemoglobin (LEH) treatment in vitro. Cytokine 8:541-547 (1996).
10. J.L. Nerad, J.K. Griffiths, J.W.M. Van der Meer, S. Endres, D.D. Poutsiaka, G.T. Keusch, M. Bennish, M.A. Salam, C.A. Dinarello and J.G. Cannon. Interleukin-1β (IL-1β), IL-1 receptor antagonist, and TNF-α production in whole blood. J. Leukoc. Biol. 52:687-692 (1992).
11. M.G. Bouma, T.M.M.A. Jeunhomme, D.L. Boyle, M.A. Dentener, N.N. Voitenok, F.A.J.M. van den Wildenberg and W.A Buurman Adenosine inhibits nentrophil degranulation in activated human whole blood. J. Immunol. 158:5400-5408 (1997).
12. J. Szebeni, N.M. Wassef, K.R. Hartman, A.S. Rudolph and C.R. Alving. Complement activation in vitro by the red cell substitute, liposome-encapsulated hemoglobin: Mechanism of activation and inhibition by soluble complement receptor type 1. Transfusion 37:150-159 (1997).
13. H. Bitterman, A. Kinarty, H. Lazarovich and N. Lahat. Acute release of cytokines is proportional to tissue injury induced by surgical trauma and shock in rats. J. Clin. Immunol 11:184-192 (1991).
14. P. Damas, D. Ledoux, M. Nys, Y. Vrindts, D. De Groote, P. Franchimont and M. Lamy Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 215:356-362 (1992).
15. Y. Oka, A. Murata, J. Nishijima, T. Yasuda, N. Hiraoka, Y. Ohmachi, K, Kitagawa, T. Yasuda, H. Toda, N. Tanaka and T. Mori. Circulating interleukin 6 as a useful marker for predicting postoperative complications. Cytokine 4:298-304 (1992).